Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Jones

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|December 9, 2009
Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)Sharmila Sivendran, Victoria Jones, Dianqing Sun, et al.
Bioorganic & Medicinal Chemistry|April 24, 2009
Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activityDianqing Sun, Michael S Scherman, Victoria Jones, et al.
Applied and Environmental Microbiology|November 20, 2012
Mycobacteriophage Ms6 LysA: a peptidoglycan amidase and a useful analytical toolSebabrata Mahapatra, Charles Piechota, Filipa Gil, et al.
The Journal of Biological Chemistry|May 22, 2019
Disruption of the SucT acyltransferase in <i>Mycobacterium smegmatis</i> abrogates succinylation of cell envelope polysaccharidesZuzana Palčeková, Shiva K Angala, Juan Manuel Belardinelli, et al.
The Australian Journal of Rural Health|February 18, 2015
Oncology service initiatives and research in regional AustraliaCaitlin Murphy, Sabe Sabesan, Christopher Steer, et al.
Mbio|June 21, 2018
Cytokinin Signaling in Mycobacterium tuberculosisMarie I Samanovic, Hao-Chi Hsu, Marcus B Jones, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosisWei Li, Ashutosh Upadhyay, Fabio L Fontes, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic propertiesE Jeffrey North, Michael S Scherman, David F Bruhn, et al.
ACS Infectious Diseases|April 22, 2015
Covalent modification of the <i>Mycobacterium tuberculosis</i> FAS-II dehydratase by Isoxyl and ThiacetazoneAnna E Grzegorzewicz, Nathalie Eynard, Annaïk Quémard, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
<i>Mycobacterium tuberculosis</i> is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsAStefan Köster, Sandeep Upadhyay, Pallavi Chandra, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|December 9, 2009
Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)Sharmila Sivendran, Victoria Jones, Dianqing Sun, et al.
Bioorganic & Medicinal Chemistry|April 24, 2009
Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activityDianqing Sun, Michael S Scherman, Victoria Jones, et al.
Applied and Environmental Microbiology|November 20, 2012
Mycobacteriophage Ms6 LysA: a peptidoglycan amidase and a useful analytical toolSebabrata Mahapatra, Charles Piechota, Filipa Gil, et al.
The Journal of Biological Chemistry|May 22, 2019
Disruption of the SucT acyltransferase in <i>Mycobacterium smegmatis</i> abrogates succinylation of cell envelope polysaccharidesZuzana Palčeková, Shiva K Angala, Juan Manuel Belardinelli, et al.
The Australian Journal of Rural Health|February 18, 2015
Oncology service initiatives and research in regional AustraliaCaitlin Murphy, Sabe Sabesan, Christopher Steer, et al.
Mbio|June 21, 2018
Cytokinin Signaling in Mycobacterium tuberculosisMarie I Samanovic, Hao-Chi Hsu, Marcus B Jones, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosisWei Li, Ashutosh Upadhyay, Fabio L Fontes, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic propertiesE Jeffrey North, Michael S Scherman, David F Bruhn, et al.
ACS Infectious Diseases|April 22, 2015
Covalent modification of the <i>Mycobacterium tuberculosis</i> FAS-II dehydratase by Isoxyl and ThiacetazoneAnna E Grzegorzewicz, Nathalie Eynard, Annaïk Quémard, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
<i>Mycobacterium tuberculosis</i> is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsAStefan Köster, Sandeep Upadhyay, Pallavi Chandra, et al.
Pageof 7